Clinical Trial Update: Adapting RDAD for DS [NA]

View source ↗

Summary

A clinical trial update indicates the University of Kansas Medical Center is adapting the RDAD program for individuals with Down syndrome and Alzheimer's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Down Syndrome (DS), Alzheimer's Disease (AD) | NA | Status: NOT_YET_RECRUITING